Phase I Dose Escalation of Gleevec [imatinib] in Combination With RAD001 [everolimus] Plus Hydroxyurea [hydroxycarbamide] for Patients With Recurrent Malignant Glioma
Phase of Trial: Phase I
Latest Information Update: 19 Feb 2013
At a glance
- Drugs Everolimus (Primary) ; Imatinib (Primary) ; Hydroxycarbamide
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma
- Focus Adverse reactions
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Nov 2008 Status changed from recruiting to active, no longer recruiting, reported by ClinicalTrials.gov.
- 25 Feb 2008 New trial record.